Researchers have accidentally discovered new methods to prevent flu while exploring how the virus replicates. The finding shows that different flu strains use varied strategies to invade human cells, providing new avenues for viral prevention.
Diverse Strategies of Flu Strains
Researchers noted that by identifying and targeting specific molecules required by flu viruses, their entry and replication could be hindered. The study emphasizes crucial insights into seasonal influenza, paving a way for enhanced preventive medicines. Dr. Emily Bruce from the University of Vermont hailed the potential of curiosity-driven research in developing novel flu treatment methods.
Challenges with Current Treatments
Despite the presence of vaccines and antiviral measures, Bruce highlighted the urgent need for more effective medications. Multiple flu strains exist, yet prevalent flu tests fail to distinguish between the most common, H1N1 and H3N2. Clinical treatments remain uniform for these strains.
Research Findings
Initial research aimed to map viral RNA transport within cells to form new virus particles. It used H1N1 and H3N2 strains from patients in 2022. Researchers unexpectedly found a cellular pathway obstructing virus entry into lung cells. Specifically, the depletion of the human protein Rab11B prevented H3N2 from entering cells, leaving H1N1 unaffected.
The research, published in The Journal of Virology, demonstrated a previously unknown, H3N2-specific function for Rab11B during viral entry, challenging the assumption that all flu viruses use the same entry method. Dr. Bruce compared viral entry methods to pirates employing various techniques to board ships.
Future Research Directions
While the findings provide a critical insight into viral entry pathways, they were based on isolated cell studies. Further research is necessary to assess the safety and efficacy of blocking Rab11B in the human respiratory system. The research team aims to explore if Rab11B-dependency is a core characteristic of H3N2 or unique to recent strains.
For more detailed health stories, sign up for the newsletter.

First Ebola Case Confirmed in France Amid Ongoing Congo Outbreak
Zohran Mamdani’s Picks Win Key House Primaries
Cancer Death Rates Decline in the U.S., But Disparities Remain
COVID-19 Vaccine Study Highlights Effectiveness Amid Controversy
Life Inside Biocontainment and Updates on Covid-19 Vaccine Policies
Extreme Heat Risk Spreads Across the U.S.